| General Information of Drug Metabolite (DM) (ID: DM019010) |
| DM Name |
SEP-383103
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Cytochrome P450 2D6 (CYP2D6)
|
DME0009
|
| Unclear - Unclear |
SEP-363856
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| SEP-363856 |
DR3505
|
Phase 3 |
Schizophrenia |
|
|
| References |
| 1 |
In Vitro ADME and Preclinical Pharmacokinetics of Ulotaront, a TAAR1/5-HT(1A) Receptor Agonist for the Treatment of Schizophrenia
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
